Mental Health

VA Official Praises RFK Jr.’s Psychedelics Stance, Offering Hope for Reform

A Veteran's Affairs official is hopeful that RFK Jr's psychedelics stance could bring reform and potential FDA approved treatments.

Read More

J&J’s Spravato On Track to Become a $3.5B Drug By 2028

If the current trajectory holds, J&J's Spravato could reach up to 3.5 billion dollars in annual sales by 2028.

Read More

Historic Move Could Transform Psilocybin Access for Terminally Ill Patients

The DEA requested that federal health officials conduct a medical review of psilocybin - a watershed moment for psychedelic medicine.

Read More

Compass Pathways Delivers Two Positive Phase 3 Results for Psilocybin in Depression

Compass Pathways just gave the psychedelic medicine field its biggest day in years.

Read More

Explore Psychedelic Therapy Regions